As the progress occurred 11 months after the last vaccine injection, this approach would have been potentially helpful, especially as the rising AML clone was diagnosed with the same characteristics including high WT1 expression levels as also detected at initial diagnosis. Here, WT1 is linked to acute myeloid leukemia.